Integration of perioperative features and intragraft TCF7L2 expression to predict lipid metabolic disorder in liver transplant recipients

作     者：Junbin Zhou Rongli Wei Guanghan Fan Zhengxing Lian Xuanyu Zhang Linsong Tang Zhetuo Qi Haiyang Xie Shusen Zheng Qiang Wei Xiao Xu 

作者机构：Department of Hepatobiliary and Pancreatic SurgeryPeople's Hospital of LishuiAffiliated Lishui Hospital of Wenzhou Medical UniversityThe First Affiliated Hospital of Lishui University NHFPC Key Laboratory of Combined Multi-Organ Transplantation Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang ProvinceDepartment of Hepatobiliary and Pancreatic SurgeryHangzhou First People's Hospital Department of Hepatobiliary and Pancreatic SurgeryThe First Affiliated HospitalZhejiang University School of Medicine Department of UrologyThe Second Affiliated HospitalZhejiang University School of Medicine Department of Hepatobiliary and Pancreatic SurgeryDepartment of Liver TransplantationShulan (Hangzhou) Hospital Hangzhou Medical College Zhejiang University School of Medicine 

出 版 物：《Science China Life Sciences》 (中国科学:生命科学(英文版))

年 卷 期：2025年第68卷第1期

页      面：297-299页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

基　　金：supported by the Medical and Health Technology Program in Zhejiang Province (WKJ-ZJ-2120) the National Key Research and Development Program of China (2021YFA1100500) Major Research Plan of the National Natural Science Foundation of China (92159202) Public Welfare Technology Application Research Project of Lishui City (2023SJZC110) 

摘      要：Dear Editor, Liver transplantation(LT) is the only curative therapy for patients with endstage liver disease(He et al., 2023; Ling et al., 2022). Post-transplant hypertriglyceridemia(PTHT), which has an incidence of up to 32.8% in 6 months after LT, is one of the major post-transplant complications(Toshima et al., 2020).